Resumo
Idioma original | English |
---|---|
Páginas (de-até) | 1502-1517.e23 |
Revista | Cell |
Volume | 181 |
Número de emissão | 7 |
DOIs | |
Estado da publicação | Publicado - 25 jun. 2020 |
Publicado externamente | Sim |
ODS da ONU
Este resultado contribui para o(s) seguinte(s) Objetivo(s) de Desenvolvimento Sustentável
Acesso ao documento
- 10.1016/j.cell.2020.05.035Licença:
Outros arquivos e links
Impressão digital
Mergulhe nos tópicos de investigação de “Hybrid gene origination creates human-virus chimeric proteins during infection“. Em conjunto formam uma impressão digital única.Citação
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Em: Cell, Vol. 181, N.º 7, 25.06.2020, p. 1502-1517.e23.
Resultado de pesquisa › revisão de pares
TY - JOUR
T1 - Hybrid gene origination creates human-virus chimeric proteins during infection
AU - Ho, Jessica Sook Yuin
AU - Angel, Matthew
AU - Ma, Yixuan
AU - Sloan, Elizabeth
AU - Wang, Guojun
AU - Martinez-Romero, Carles
AU - Alenquer, Marta
AU - Roudko, Vladimir
AU - Chung, Liliane
AU - Zheng, Simin
AU - Chang, Max
AU - Fstkchyan, Yesai
AU - Clohisey, Sara
AU - Dinan, Adam M.
AU - Gibbs, James
AU - Gifford, Robert
AU - Shen, Rong
AU - Gu, Quan
AU - Irigoyen, Nerea
AU - Campisi, Laura
AU - Huang, Cheng
AU - Zhao, Nan
AU - Jones, Joshua D.
AU - van Knippenberg, Ingeborg
AU - Zhu, Zeyu
AU - Moshkina, Natasha
AU - Meyer, Léa
AU - Noel, Justine
AU - Peralta, Zuleyma
AU - Rezelj, Veronica
AU - Kaake, Robyn
AU - Rosenberg, Brad
AU - Wang, Bo
AU - Wei, Jiajie
AU - Paessler, Slobodan
AU - Wise, Helen M.
AU - Johnson, Jeffrey
AU - Vannini, Alessandro
AU - Amorim, Maria João
AU - Baillie, J. Kenneth
AU - Miraldi, Emily R.
AU - Benner, Christopher
AU - Brierley, Ian
AU - Digard, Paul
AU - Łuksza, Marta
AU - Firth, Andrew E.
AU - Krogan, Nevan
AU - Greenbaum, Benjamin D.
AU - MacLeod, Megan K.
AU - van Bakel, Harm
AU - Garcìa-Sastre, Adolfo
AU - Yewdell, Jonathan W.
AU - Hutchinson, Edward
AU - Marazzi, Ivan
N1 - Funding Information: We thank the Genomics and Mouse facility at Icahn School of Medicine at Mount Sinai, the Global Health and Emerging Pathogens Institute (GHEPI) at Mount Sinai, and the entire Marazzi Lab team. The authors would also like to thank Ervin Fodor, University of Oxford for support and critical comments on the project; Svenja Hester, Benjamin Thomas, and Shabaz Mohammed of the Advanced Proteomics Facility, University of Oxford for proteomics; Elly Gaunt, University of Edinburgh and Michael Goodin, University of Kentucky, for critical reading of the manuscript; and staff within the Institute of Infection, Immunity, and Inflammation Flow Cytometry Facility, the Central Research Facility at the University of Glasgow, Thomas Purnell of the Institute of Infection, Immunity and Inflammation, University of Glasgow and Dimitris Athineos of the Beatson Institute for technical assistance and discussion. I.M. is supported by the Burroughs Wellcome Fund (United States; 1017892) and by the Chan Zuckerberg Initiative (United States; 2018-191895). I.M. and H.v.B. are supported by the NIH (United States; R01AI113186). A.G.-S. and I.M. are supported by the NIH (U19AI135972 FLUOMICS). E.H. E.S. and Q.G. are supported by an MRC (United Kingdom) Career Development Award (MR/N008618/1), and E.H. carried out proteomics work when funded by an MRC Programme Grant to Prof. Ervin Fodor, University of Oxford (MR/K000241/1). V.R. and I.v.K. were supported by a Wellcome Trust (United Kingdom) Senior Investigator award (099220/Z/12/Z) awarded to Prof. Richard M. Elliott, University of Glasgow. R.G. and Q.G. were supported by the MRC (MC_UU_12014/12). J.K.B. was supported by a Wellcome Trust Intermediate Clinical Fellowship (103258/Z/13/Z), a Wellcome-Beit Prize (103258/Z/13/A), and the UK Intensive Care Society. J.K.B. and S.C. acknowledge the BBSRC (United Kingdom) Institute Strategic Programme Grant to the Roslin Institute. B.W. was supported by a SHIELD (MR/N02995X/1) Edinburgh Global Research Scholarship. A.E.F. was supported by the Wellcome Trust (106207) and European Research Council (European Union; 646891). I.B. P.D. and H.M.W. were supported by an MRC project grant (MR/M011747/1). P.D. was supported by the BBSRC Institute Strategic Programme (BB/J004324/1 and BB/P013740/1). J.D.J. was funded by a Wellcome Trust PhD scholarship. M. Alenquer and M.J.A. were supported by the FCT (Portugal) award PTDC/BIA-CEL/32211/2017 and IF/00899/2013, respectively. M.K.M. was supported by a Wellcome Investigator Award (210703/Z/18/Z). Conceptualization, I.M. E.H. A.G.-S. J.W.Y. and E.S.; Methodology, I.M. J.W.Y. Y.M. M.A. G.W. and J.S.Y.H.; Formal Analysis, Y.M. M.A. G.W. J.S.Y.H. N.Z. J.N. N.M. J.G. J.W. J.J. M.C. Z.P. H.v.B. M.L. E.R.M. and A.E.F.; Investigation, J.S.Y.H. M.A. Y.M. E.S. G.W. C.M.-R. M.A. V.R. L. Campisi, S.Z. M.C. Y.F. S.C. A.M.D. J.G. R.G. R.S. Q.G. N.I. L. Chung, N.Z. J.D.J. I.v.K. Z.Z. N.M. L.M. J.N. Z.P. V.R. R.K. B.R. B.W. J.W. H.W. J.J. A.V. M.J.A. E.R.M. C.B. I.B. P.D. M.L. A.E.F. N.K. B.D.G. M.K.M. and H.v.B.; Data Curation, M.A. Y.M. H.v.B. R.G. and J.J.; Resources, Y.M. M.A. J.J. M.C. H.v.B. E.R.M. A.G.-S. S.P. and C.H.; Writing ? Original Draft, I.M. and E.H.; Writing ? Review & Editing, E.H. I.M. J.W.Y. Y.M. J.S.Y.H. M.A. E.S. A.M.D. H.v.B. M.L. B.D.G. E.R.M. A.G.-S. P.D. and A.E.F.; Visualization, E.H. Y.M. M.A. G.W. J.H. J.J. M.C. Z.P. E.R.M. and Z.Z.; Funding Acquisition, A.G.-S. I.M. J.K.B. A.E.F. I.B. P.D. M.J.A. E.H. and M.K.M.; Project Administration, I.M. and E.H.; Supervision, E.H. and I.M. The authors declare no competing interests. Funding Information: We thank the Genomics and Mouse facility at Icahn School of Medicine at Mount Sinai, the Global Health and Emerging Pathogens Institute (GHEPI) at Mount Sinai, and the entire Marazzi Lab team. The authors would also like to thank Ervin Fodor, University of Oxford for support and critical comments on the project; Svenja Hester, Benjamin Thomas, and Shabaz Mohammed of the Advanced Proteomics Facility, University of Oxford for proteomics; Elly Gaunt, University of Edinburgh and Michael Goodin, University of Kentucky, for critical reading of the manuscript; and staff within the Institute of Infection, Immunity, and Inflammation Flow Cytometry Facility, the Central Research Facility at the University of Glasgow, Thomas Purnell of the Institute of Infection, Immunity and Inflammation, University of Glasgow and Dimitris Athineos of the Beatson Institute for technical assistance and discussion. I.M. is supported by the Burroughs Wellcome Fund (United States; 1017892 ) and by the Chan Zuckerberg Initiative (United States; 2018-191895 ). I.M. and H.v.B. are supported by the NIH (United States; R01AI113186 ). A.G.-S. and I.M. are supported by the NIH ( U19AI135972 FLUOMICS ). E.H., E.S., and Q.G. are supported by an MRC (United Kingdom) Career Development Award ( MR/N008618/1 ), and E.H. carried out proteomics work when funded by an MRC Programme Grant to Prof. Ervin Fodor, University of Oxford ( MR/K000241/1 ). V.R. and I.v.K. were supported by a Wellcome Trust (United Kingdom) Senior Investigator award ( 099220/Z/12/Z ) awarded to Prof. Richard M. Elliott, University of Glasgow. R.G. and Q.G. were supported by the MRC ( MC_UU_12014/12 ). J.K.B. was supported by a Wellcome Trust Intermediate Clinical Fellowship ( 103258/Z/13/Z ), a Wellcome-Beit Prize ( 103258/Z/13/A ), and the UK Intensive Care Society . J.K.B. and S.C. acknowledge the BBSRC (United Kingdom) Institute Strategic Programme Grant to the Roslin Institute. B.W. was supported by a SHIELD ( MR/N02995X/1 ) Edinburgh Global Research Scholarship. A.E.F. was supported by the Wellcome Trust ( 106207 ) and European Research Council (European Union; 646891 ). I.B., P.D., and H.M.W. were supported by an MRC project grant ( MR/M011747/1 ). P.D. was supported by the BBSRC Institute Strategic Programme ( BB/J004324/1 and BB/P013740/1 ). J.D.J. was funded by a Wellcome Trust PhD scholarship. M. Alenquer and M.J.A. were supported by the FCT (Portugal) award PTDC/BIA-CEL/32211/2017 and IF/00899/2013 , respectively. M.K.M. was supported by a Wellcome Investigator Award ( 210703/Z/18/Z ). Publisher Copyright: © 2020 The Authors
PY - 2020/6/25
Y1 - 2020/6/25
N2 - RNA viruses are a major human health threat. The life cycles of many highly pathogenic RNA viruses like influenza A virus (IAV) and Lassa virus depends on host mRNA, because viral polymerases cleave 5′-m7G-capped host transcripts to prime viral mRNA synthesis (“cap-snatching”). We hypothesized that start codons within cap-snatched host transcripts could generate chimeric human-viral mRNAs with coding potential. We report the existence of this mechanism of gene origination, which we named “start-snatching.” Depending on the reading frame, start-snatching allows the translation of host and viral “untranslated regions” (UTRs) to create N-terminally extended viral proteins or entirely novel polypeptides by genetic overprinting. We show that both types of chimeric proteins are made in IAV-infected cells, generate T cell responses, and contribute to virulence. Our results indicate that during infection with IAV, and likely a multitude of other human, animal and plant viruses, a host-dependent mechanism allows the genesis of hybrid genes.
AB - RNA viruses are a major human health threat. The life cycles of many highly pathogenic RNA viruses like influenza A virus (IAV) and Lassa virus depends on host mRNA, because viral polymerases cleave 5′-m7G-capped host transcripts to prime viral mRNA synthesis (“cap-snatching”). We hypothesized that start codons within cap-snatched host transcripts could generate chimeric human-viral mRNAs with coding potential. We report the existence of this mechanism of gene origination, which we named “start-snatching.” Depending on the reading frame, start-snatching allows the translation of host and viral “untranslated regions” (UTRs) to create N-terminally extended viral proteins or entirely novel polypeptides by genetic overprinting. We show that both types of chimeric proteins are made in IAV-infected cells, generate T cell responses, and contribute to virulence. Our results indicate that during infection with IAV, and likely a multitude of other human, animal and plant viruses, a host-dependent mechanism allows the genesis of hybrid genes.
KW - Cap-snatching
KW - Chimeric proteins
KW - Gene origination
KW - Influenza
KW - RNA hybrid
KW - Segmented negative-strand RNA viruses
KW - uORFs
KW - Upstream AUG
KW - Viral evolution
KW - Viral RNA
UR - http://www.scopus.com/inward/record.url?scp=85086715075&partnerID=8YFLogxK
U2 - 10.1016/j.cell.2020.05.035
DO - 10.1016/j.cell.2020.05.035
M3 - Article
C2 - 32559462
AN - SCOPUS:85086715075
SN - 0092-8674
VL - 181
SP - 1502-1517.e23
JO - Cell
JF - Cell
IS - 7
ER -